VOTING STARTS NOW

Back your favourite finalist team to help select the #IoiTHack winner for 2021!

m a r i a m
8 min readJun 1, 2021

The Internet-of-Ingestible-Things™ Series

As co-founder of Enteromics and PhD in Cyber-biosecurity, I launch the very first Internet-of-Ingestible-Things Hackathon, sponsored by the Dawes Centre for Future Crime, as a series of workshops bringing together experts from cybersecurity with medical device regulatory bodies and makers, to help design security for the new generation “Ingestible-Things” or secure smart gut-sensing pills.

The time has finally come. After three months of the very first Internet-of-Ingestible-Things™ Hackathon, it is time for the DEMO BATTLE: Finalist Teams pitch their final Ingestible-Things™ proposal to our expert Judges Panel one last time. Out of all the Finalist Teams, the Judges and the Public choose The Winner of this year’s #IoiTHack series.

BUT WE NEED YOUR HELP!

Show your support for your favourite Ingestible Thing™ device and team by liking, commenting and sharing their 2-min pitch video, now! The team with the most support from the public will have a higher chance of winning.

The Internet-of-Ingestible-Things™ Series

Here is a quick re-cap of the Ingestible Things™ Series (read more here, here, and here). The teams have conducted a red teaming exercise on their Ingestible Things™ devices to help design in security to safeguard against potential adversary threats. They’ve also taken part in the Security-by-design study through a Hybrid Hackathon Delphi Model (HDDM)(more on this to come soon— stay tuned!), supported by the Dawes Centre for Future Crime.

UCL’s Institute of Making collaborated with Enteromics to provide the finalist teams with an induction session on how to turn paper sketches of their Ingestible Things™ devices into actual 3D models using Fusion 360 software. Finally, we invited Mark Corbett, Director of Edvent/ThrustCarbon and previous coach at the Mayor’s Entrepreneur Programme, to get the finalist teams “pitch ready”.

We 3D-printed the finalist teams Ingestible Things™ device prototypes to show-off in their 2-min pitch videos.

BUT FIRST, SOME BLOOPERS

Some Ingestible Things™ design attempts from the finalists teams resulted in a wanna-be perfume bottle, a spherical UFO and the flight of the navigator, what do you think?

COMMENT BELOW!

NOW FOR THE REAL STUFF.

SmarTrace, for every cruise case.

A Neuroscientist, a multi-award winning pharmacist and a NextGenTech Growth Manager are tackling a very timely issue: norovirus outbreak control — on ships!

The SmarTrace team focuses on a niche but extremely challenging problem of tracing highly contagious infections such as the Norovirus, on cruise ships during quarantine.

Despite lockdown and additional measures implemented in the last year while facing COVID19, major cruise liners have reported a failure to successfully control the virus as over 11% of their passengers were infected.

The SmarTrace team is uniquely introducing a private blockchain to their proposed solution for secure and transparent data transmission — follow them as they take a deeper dive on the design for their Ingestible-Things™ device that will allow for rapid identification of infected individuals.

Link: https://youtu.be/0-GqzMQZaW4

Make sure you use #IoiTHack1 when sharing, liking and commenting!

Power to the patient with BiotAI.

What’s had a 290% increase in the last 5 years? Gut Health Research.

Yet it is difficult to get a full picture of the “gut microbiome” — or ecosystem of microorganisms that reside in your gut and are responsible for your digestion and health — due to limitations with methods in accessing and analysing the gut.

With the race to understand the ‘perfect’ gut microbiome, the BiotAI team is on a mission to provide an easy-to-use Ingestible-Things™ device, jumping on the new consumer trend to track one’s body by giving power to the patient.

10–15% of the worldwide population is estimated to suffer from some gastrointestinal issue, keep track of BiotAI as they cater for a rapid but secure cloud communication system.

Link: https://youtu.be/OyPczjnOBdM

Make sure you use #IoiTHack2 when sharing, liking and commenting

Inflammation: Locate and Deactivate.

What happens when an Electronic Engineer, a Medical and Management strategist and a Computational Mathematician meet? IBDeactivate is born: a team proposing an Ingestible-Things™ device for targeted drug release, while addressing security and privacy concerns of patients and clinicians.

More than 3 million people in the USA and Europe have inflammatory bowel disease (IBD), a chronic condition of inflammation in gut that can cause various symptoms from severe abdominal pain to bleeding and surgery.

IBDeactivate team has specialist skills in embedded systems for IoT, and will be prototyping an Ingestible-Things™ device design for targeted micro-dosing of anti-inflammatory drugs in the gut but with firmware coding and telecommunication security needs for clinical and patient acceptance. Follow their journey in addressing key privacy questions such as are medical practitioners confident enough to supply Ingestible-Things™ devices to patients? Are patients comfortable with ingesting an Ingestible-Things™ device?

Link: https://youtu.be/SmLjN77F8RI

Make sure you use #IoiTHack3 when sharing, liking and commenting

The winning team will be selected and judged by the following criteria:

  1. SECURITY DESIGN— 30%
  2. PROTOTYPE — 20%
  3. PUBLICS VOTE — 20%
  4. OVERALL PITCH — 30%

Ready to meet our experts?

Meet our Expert Judging Panel

Our first judge is a physicist by background, and has spent the last 8 years working in medical device development. Meet Tom Beale, who has completed his PhD in experimental condensed matter physics at Durham University in 2006 and subsequently spend several years as a research associate designing experimental equipment for national experimental facilities. Tom then joined the Newcastle Hospitals NHS Trust where he worked within clinical engineering, designing and developing diagnostic and therapeutic medical devices for commercial exploitation and providing guidance for regulatory compliance. Tom has provided specialist regulatory consultancy for a number of start-up and small companies and retains strong links to regional NHS organisations. For the last three years he has been the Commercial Development Manager for Medtech at CPI, assisting companies in the design, development and scale up of medical diagnostic and therapeutic technologies.

Next we have Fotios Chantzis, a security engineer at OpenAI who is laying the foundation for a safe and secure Artificial General Intelligence (AGI)!

Previously, he worked as a principal information security engineer at Mayo Clinic, where
he managed and conducted technical security assessments on medical devices, clinical support systems, and critical healthcare infrastructure.

He has been a member of the core Nmap development team since 2009, when he wrote Ncrack under the mentorship of Gordon “Fyodor” Lyon, the original
author of Nmap, during the Google Summer of Code.

For those who may not know, Nmap (Network Mapper) is a free and open-source network scanner, now one of the core tools used by network administrators to map their networks. The program can be used to find live hosts on a network, perform port scanning, ping sweeps, OS detection, and version detection. Fotis is a security engineer specialist with a research focus on network exploitation and IoT — Lead author of recently published “Practical IoT Hacking”. Fotis has presented at notable security conferences, including DEF CON. Highlights of his work can be found at his site https://sock-raw.org/.

Last but certainly not least, we we have Uri, a veteran Cyber security professional with hands-on experience leading and building cyber security practices across various geographies and sectors. With proven track record of strategic leadership, forward thinking, business development and client relationship development in multinational environments for over 20 years Uri have been a trusted advisor to the CXO level, developing, communicating and executing Cyber Security strategies to executives and board members.

OK, so how do I vote for the finalist teams?

Social media sharing, full steam ahead!

If you want your favourite team to take the win — a cash prize of £1000, sponsored by the Dawes Centre for Future Crime, and manufacturing opportunities with Enteromics Ltd. — then start voting!

To vote, use the following links to share the video of your favorute team, like the posts and comment! Dont forget to use the hashtag allocated to each team!

THREE TEAMS, TWO WEEKS AND ONLY ONE WINNER!

Winners will be announced on the 18th of June.

INTERNET-OF-INGESTIBLE-THINGS™: WHY NOW?

Watch a 3-min video explaining why we have launched the very first Internet-of-Ingestible-Things™ series!

WATCH HERE: https://lnkd.in/dMgXd5X

Were you eager to take part in the Internet-of-Ingestible-Things #IoiTHack but didn’t get a chance to this year?

Fill in this quick form to be the first to know for the next one! https://vcx1vh0xjld.typeform.com/to/Zmw7ZuB1

Are you a professional within the digital biosecurity or cyber-biosecurity space? Do you want to keep track of news, events and developments within the community?

Join our network here: https://vcx1vh0xjld.typeform.com/to/W4NOEzXN

The Internet-of-Ingestible-Things series and hackathon is led by Mariam Elgabry, Co-founder and Director of Enteromics, a MedTech start-up that builds smart gut-sensing pills that once swallowed connect to a smart phone via an App to deliver AI-powered gut health insights; moving healthcare to the comfort of the home.

Mariam’s background is in deep-tech and bioengineering, holding a MSc in Bioinformatics & Theoretical Systems Biology from Imperial College London, as well as a MRes in Security & Crime Science from the University College London (UCL). Alongside her role at Enteromics, she researches Bio-crime, the Internet-of-Medical-Things (IoMT), and Cyber-biosecurity as part of her PhD research at the Dawes Centre for Future Crime, UCL. Her most recent work discusses the COVID-19 pandemic and its effect on Cyber-biosecurity in the UK and abroad; published by the UK Parliament Joint Committee on National Security.

Mariam’s experience lies at the intersection of industry and research, focusing on tech, health and security. At AstraZeneca, She led an award winning technology for early detection systems in drug testing. Later, as a Lead Microsoft Student Partner, she had the opportunity to help translate technology and innovative tools, from hackathons into start-ups. Alongside her studying, her work as a Sergeant at the London Metropolitan Police exposed her to operations on the field, including risk mitigation — from managing policing activity, to effective deployment of resources to incidents; skills later applied in her work as a Security Design Consultant.

Get Mariam Elgabry’s stories in your inbox

--

--